X0303 4 2008-08-05 0 0001173657 BARRIER THERAPEUTICS INC BTRX 0001106607 JP MORGAN PARTNERS BHCA LP 270 PARK AVENUE NEW YORK NY 10017 0 0 1 0 0001243235 JPMP MASTER FUND MANAGER L P C/O JPMORGAN PARTNERS LLC 270 PARK AVENUE 39TH FLOOR NEW YORK NY 10017 0 0 1 0 0001330534 JPMP CAPITAL CORP C/O J.P. MORGAN PARTNERS, LLC 270 PARK AVENUE, 39TH FLOOR NEW YORK NY 10017 0 0 1 0 0001162622 JP MORGAN PARTNERS GLOBAL INVESTORS LP C/O J.P. MORGAN PARTNERS, LLC 270 PARK AVENUE, 39TH FLOOR NEW YORK NY 10017 0 0 1 0 0001167095 J P MORGAN PARTNERS GLOBAL INVESTORS A LP 270 PARK AVENUE, 39TH FLOOR NEW YORK NY 10017 0 0 1 0 0001169890 J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP C/O J.P. MORGAN PARTNERS, LLC 270 PARK AVENUE, 39TH FLOOR NEW YORK NY 10017 0 0 1 0 0001169889 J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP C/O J.P. MORGAN PARTNERS, LLC 270 PARK AVENUE, 39TH FLOOR NEW YORK NY 10017 0 0 1 0 0001317638 JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN LLP C/O J.P. MORGAN PARTNERS, LLC 270 PARK AVENUE, 39TH FLOOR NEW YORK NY 10017 0 0 1 0 0001281161 JPMP GLOBAL INVESTORS L P C/O J.P. MORGAN PARTNERS, LLC 270 PARK AVENUE, 39TH FLOOR NEW YORK NY 10017 0 0 1 0 Common Stock 2008-08-05 4 U 0 2005715 4.15 D 0 D Common Stock 2008-08-05 4 U 0 332807 4.15 D 0 I See Footnote Common Stock 2008-08-05 4 U 0 168617 4.15 D 0 I See Footnote Common Stock 2008-08-05 4 U 0 46312 4.15 D 0 I See Footnote Common Stock 2008-08-05 4 U 0 18801 4.15 D 0 I See Footnote Common Stock 2008-08-05 4 U 0 84588 4.15 D 0 I See Footnote Option (right to purchase) 2.71 2008-08-06 4 D 0 10000 D 2018-06-04 Common Stock 10000 0 I See Footnote The amount shown includes 1,093,966 shares held of record by the Bank of New York ("BONY") as Voting Trustee. BONY, as Voting Trustee has the voting power over such shares while the Reporting Person has retained dispositive power over such shares. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors, L.P. The Reporting Person has no pecuniary interest in such securities. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors (Cayman), L.P. The Reporting Person has no pecuniary interest in such securities. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors A, L.P. The Reporting Person has no pecuniary interest in such securities. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors (Cayman) II, L.P. The Reporting Person has no pecuniary interest in such securities. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors (Selldown), L.P. ("Selldown"). The amount shown includes 62,546 shares held by BONY as Voting Trustee. BONY as Voting Trustee has the voting power over such shares while Selldown has retained dispositive power over such shares. The Reporting Person has no pecuniary interest in such securities. Shares were tendered in connection with the Agreement and Plan of Merger dated June 23, 2008 between Barrier Therapeutics, Inc., Stiefel Laboratories, Inc. and Bengal Acquisition Inc. (the "Merger"). This option was canceled in connection with the Merger in exchange for the right to receive the difference between the merger consideration of $4.15 per share and the option exercise price. /s/ John C. Wilmot, Managing Director, J.P. Morgan Partners (BHCA), L.P., JPMP Master Fund Manager, L.P., its general partner, JPMP Capital Corp., its general partner 2008-08-08